Next, we carried out in vitro studies in a human lung adenocarcinoma-derived cell line, A549, with the aim of providing a mechanistic explanation of how reduced expression of RNPC3 causes a decrease in tumour burden in the various in vivo cancer models. Here, RNPC3 is linked to lung adenocarcinoma.